Genentech

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  

Genentech
Dec 4, 2024, 09:54 | Positive
100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2024
Starting on August 26, in honor of Women’s Equality Day in the United States, which…
Nov 26, 2024, 14:18 | Insight
Record breaking $29 Million Raised for VeloSano Cancer Research Accelerator Fund at Cleveland Clinic
The Cleveland Clinic’s VeloSano Cancer Research Accelerator Fund raised a record-breaking $29 million in 2024.…
Nov 22, 2024, 12:36 | Insight
Regulating the Hippo pathway with the New class of TEAD small molecule inhibitors
Anirban Maitra shared a post on X: "And right on cue! Preprint from Genentech on a…
Nov 12, 2024, 19:13 | Insight
Anirban Maitra: Targeting the Hippo pathway in cancer by Anwesha Dey and colleagues
Anirban Maitra, Professor of Pathology and Translational Molecular Pathology at UT MD Anderson Cancer Center,…
Oct 27, 2024, 11:00 | Insight
Combining targeted therapy and immunotherapy improves overall survival in patients with anaplastic thyroid carcinoma
Approach achieved longest median overall survival published to date for systematic therapy in anaplastic thyroid…
Oct 15, 2024, 00:11 | Insight
Akshat Jain: US FDA approves Marstacimab for Hemophilia A or B without inhibitors in adults and adolescents
Akshat Jain shared a post on X: "U.S. FDA approves Pfizer Marstacimab for the treatment of…
Oct 8, 2024, 15:11 | Blog
Ashley Magargee: My 20th anniversary at Genentech
Ashley Magargee shared on LinkedIn: "Last month officially marked my 20th anniversary at Genentech! I…
Oct 2, 2024, 14:06 | Blog
Aakash Desai: Excited for the IMPACT-NSCLC study presented at ASCO Quality Care Symposium
Aakash Desai, Assistant Professor, UAB O'Neal Comprehensive Cancer Center, shared a post by Shashi Shankar,…
Sep 26, 2024, 13:58 | Blog
Renjith Vijayakumar Selvarani: A Turning Point for Cancer Vaccines
Renjith Vijayakumar Selvarani, Founder, Chairman, Chief Scientific and Technology Officer at OLUSIUM, shared a post…
Sep 14, 2024, 10:15 | Career
Melinda Aldrich has been appointed to the ASHG Board of Directors
Melinda Aldrich was recently elected to the (American Society of Human Genetics) ASHG Board of…
Aug 11, 2024, 21:32 | Blog
Full power of innovation to achieve the goals of The White House Cancer Moonshot initiative - Genomate Health
Genomate Health posted on LinkedIn: "As a CancerX Moonshot founding member, we collaborate with other…
Aug 11, 2024, 19:26 | Blog
Know Your Biomarkers: The 'Ask About ALK' Campaign
ALK Positive Inc. posted on LinkedIn: "Sponsored by Genentech. When Nikki was diagnosed with lung…
Aug 8, 2024, 11:55 | Blog
Why it’s important to talk to a healthcare provider about biomarker testing - ALK Positive Inc.
ALK Positive Inc. shared a post on LinkedIn: ''Sponsored by Genentech. For Mike, finding out…
Jul 24, 2024, 14:01 | Blog
Eleni Taoula: Complex global regulatory landscape for ADCs
Eleni Taoula, Associate Professor at The University of Nicosia Medical School, shared on LinkedIn:  "ADC drugs…
Jul 22, 2024, 16:46 | Insight
Friends HRD Harmonization Project with Patsy Hinson - Friends of Cancer Research
Friends of Cancer Research shared on X: "It is very important for patients to have…
Jul 2, 2024, 10:32 | Insight
Trastuzumab emtansine (T-DM1) is highly effective in preventing stage 1 HER2-positive breast cancer from recurring - MedEdge MEA
MedEdge MEA shared a post on LinkedIn:  . "A year of treatment with a medicine…
Jun 29, 2024, 15:03 | Insight
IO inductive therapy let 25% unresectable stage 3 NSCLC become resectable
Thomas Wu, Research physician at Genentech, shared a post by  X: "Our paper just out…
Jun 9, 2024, 08:07 | Blog
Ashley Magargee: I am so proud that Genentech is part of the Biden Cancer Moonshot program
Ashley Magargee, Chief Executive Officer at Genentech, shared a post by Genentech on LinkedIn: "We…
May 23, 2024, 20:08 | Blog
Maria Babak: Join the UNITY Summit organized by The University of Illinois Cancer Center and don't forget about the OncoParty2024
Maria Babak shared a post by Shikha Jain on LinkedIn: "If you are attending ASCO this year,…
May 16, 2024, 16:51 | Insight
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
In the fast-growing field of oncology, we are witnessing significant advances in several treatment modalities…
May 12, 2024, 15:42 | Insight
Sumanta Pal: Proud of this project on two levels
Sumanta Pal, Professor in the Department of Medical Oncology at City of Hope Medical Center,…
May 11, 2024, 00:51 | Career
Joni Fausett: I joined Kite Pharma as the Head of US Medical Affairs
Joni Fausett, Head of US Medical Affairs at Kite Pharma, made the following post on…
May 9, 2024, 15:31 | Blog
Hedyeh Ebrahimi: Unique challenges that community cancer centers face to engage in oncology clinical trials
Hedyeh Ebrahimi, Postdoctoral fellow at Genitourinary Cancer Research Team of City of Hope, shared a post…
May 7, 2024, 13:55 | Blog
Karen Knudsen: Genentech reflects the depth and breadth of our commitments to improving the lives of cancer patients
Karen Knudsen shared a post by American Cancer Society on LinkedIn, adding: "Our work with…
Apr 23, 2024, 10:07 | Insight
Ashley Magargee: Fortunate to have leading computational biology experts like Aviv Regev advancing our understanding of cancer like never before
Ashley Magargee, Chief Executive Officer at Genentech, shared on LinkedIn: "We’re fortunate to have leading…
Apr 19, 2024, 15:52 | Drugs
FDA approves alectinib as adjuvant treatment for ALK-positive non-small cell lung cancer based on ALINA trial
FDA, the Food and Drug Administration approved alectinib (Alecensa, Genentech, Inc.) for adjuvant treatment following…
Apr 13, 2024, 09:17 | Societies
30 Posts Not To Miss From AACR24!
The AACR Annual Meeting 2024 was held from April 5th to 10th in San Diego,…
Apr 10, 2024, 08:53 | Insight
Vivek Subbiah: Cell atlas projects have contributed to our understanding of cancers
Vivek Subbiah shared on X/Twitter: "We have learned a lot from cell atlas projects -…
Feb 23, 2024, 17:26 | Blog
Elad Sharon: Honored to receive a plaque for our team’s work getting the first immune checkpoint inhibitor approved in sarcoma!
Elad Sharon, Medical Oncologist at Dana-Farber Cancer Institute, made the following post on X: "Honored…
Dec 13, 2023, 11:08 | Career
Genentech Welcomes Ashley Magargee as New CEO: A 20-Year Journey of Excellence and Leadership
Genentech shared today on LinkedIn: "We are excited to share that Ashley Magargee has been…
Dec 10, 2023, 17:54 | Blog
Christian Rutzer: Roche and Novartis - Basel's Research and Innovation Powerhouses
Christian Rutzer, Deputy Head and Lead Scientist at the CIEB University of Basel, shared on…
Nov 23, 2023, 15:53 | Blog
David Paragamian: Our Recently Diagnosed? Podcast is a Gold MarCom Award-winner
David Paragamian, Chief Executive Officer at Health Monitor Network, posted on LinkedIn: "Our Recently Diagnosed?…
Oct 12, 2023, 01:34 | Opinion
Alexander Hardy: Today, we're commemorating a significant milestone at Genentech - the 25th anniversary of a groundbreaking medicine for patients with HER2+ metastatic breast cancer.
Aug 3, 2023, 19:36 | Blog
I look forward to relocating back to the east coast to begin a new adventure in drug discovery and development - Mark McCarron
A professor and a venture capitalist walk into a bar…and the rest is history. I’ve…
All: 34 Posts: 1 - 100
Special Coverage